AGF Investments Inc’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-140,229
Closed -$30.4M 840
2021
Q1
$30.4M Buy
140,229
+30,000
+27% +$5.64M 0.24% 128
2020
Q4
$12.7M Sell
110,229
-84
-0.1% -$9.41K 0.11% 171
2020
Q3
$10.7M Hold
110,313
0.11% 175
2020
Q2
$13.5M Buy
110,313
+40,000
+57% +$4.54M 0.14% 163
2020
Q1
$6.16M Buy
70,313
+37,165
+112% +$3.94M 0.07% 189
2019
Q4
$3.47M Hold
33,148
0.04% 212
2019
Q3
$3.81M Sell
33,148
-57
-0.2% -$8.65K 0.05% 199
2019
Q2
$5.72M Buy
+33,205
New +$5.74M 0.07% 179
2018
Q2
Sell
-5,102
Closed -$575K 369
2018
Q1
$575K Sell
5,102
-5,087
-50% -$640K 0.01% 314
2017
Q4
$1.34M Buy
+10,189
New +$1.2M 0.01% 291

Other funds holding GWPH

AGF Investments Inc's GWPH Position: Q2 2021 in Review

AGF Investments Inc sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 140,229 shares — an estimated $30.4M sold.

AGF Investments Inc first reported a position in GWPH in Q4 2017 and held it in 10 quarters. The position peaked at $30.4M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • AGF Investments Inc reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • AGF Investments Inc sold 140,229 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $30.4M.
  • AGF Investments Inc first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 10 quarters.
  • AGF Investments Inc's GW Pharmaceuticals Plc American Depositary Shares position peaked at $30.4M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on AGF Investments Inc's 13F filing for Q2 2021, filed 10 Aug 2021.